{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:33:06Z","timestamp":1777509186628,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011096","name":"Jazz Pharmaceuticals","doi-asserted-by":"publisher","award":["SKL-N05"],"award-info":[{"award-number":["SKL-N05"]}],"id":[{"id":"10.13039\/100011096","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.chest.2024.10.050","type":"journal-article","created":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T05:00:21Z","timestamp":1731128421000},"page":"863-875","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Results of the Solriamfetol's Effect on Cognitive Health in Apnea Participants During a Randomized Placebo-Controlled Study (SHARP)"],"prefix":"10.1016","volume":"167","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4678-2971","authenticated-orcid":false,"given":"Hans P.A.","family":"Van Dongen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7389-6384","authenticated-orcid":false,"given":"Eileen B.","family":"Leary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5486-3587","authenticated-orcid":false,"given":"Christopher","family":"Drake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7043-2974","authenticated-orcid":false,"given":"Richard","family":"Bogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3396-5402","authenticated-orcid":false,"given":"Judith","family":"Jaeger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7777-2454","authenticated-orcid":false,"given":"Caroline","family":"Streicher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herriot","family":"Tabuteau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.chest.2024.10.050_bib1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.sleep.2016.02.008","article-title":"A\u00a0review of neurocognitive function and obstructive sleep apnea with or without daytime sleepiness","volume":"23","author":"Zhou","year":"2016","journal-title":"Sleep Med"},{"issue":"4","key":"10.1016\/j.chest.2024.10.050_bib2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/jsr.12039","article-title":"Residual sleepiness in sleep apnea patients treated by continuous positive airway pressure","volume":"22","author":"Gasa","year":"2013","journal-title":"J\u00a0Sleep Res"},{"issue":"5","key":"10.1016\/j.chest.2024.10.050_bib3","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1183\/09031936.00016808","article-title":"Prevalence of residual excessive sleepiness in CPAP-treated sleep apnoea patients: the French multicentre study","volume":"33","author":"Pepin","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.chest.2024.10.050_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.690008","article-title":"Excessive daytime sleepiness in obstructive sleep apnea patients treated with continuous positive airway pressure:\u00a0data from the European Sleep Apnea Database","volume":"12","author":"Bonsignore","year":"2021","journal-title":"Front Neurol"},{"issue":"4","key":"10.1016\/j.chest.2024.10.050_bib5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5005\/jp-journals-10069-0059","article-title":"Prevalence of cognitive impairment in obstructive sleep apnea and its association with the severity of obstructive sleep apnea: a cross-sectional study","volume":"15","author":"Vasudev","year":"2020","journal-title":"Indian J Sleep Med"},{"key":"10.1016\/j.chest.2024.10.050_bib6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.sleep.2016.06.028","article-title":"Neurocognitive function in patients with residual excessive sleepiness from obstructive sleep apnea: a prospective, controlled study","volume":"26","author":"Werli","year":"2016","journal-title":"Sleep Med"},{"issue":"1","key":"10.1016\/j.chest.2024.10.050_bib7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41598-019-56478-9","article-title":"Association between excessive daytime sleepiness, REM phenotype and severity of obstructive sleep apnea","volume":"10","author":"Gabryelska","year":"2020","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.chest.2024.10.050_bib8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.smrv.2013.08.002","article-title":"Evaluation of the measurement properties of the Epworth Sleepiness Scale: a systematic review","volume":"18","author":"Kendzerska","year":"2014","journal-title":"Sleep Med Rev"},{"issue":"12","key":"10.1016\/j.chest.2024.10.050_bib9","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1080\/17476348.2018.1541742","article-title":"Solriamfetol for the treatment of daytime sleepiness in obstructive sleep apnea","volume":"12","author":"Abad","year":"2018","journal-title":"Expert Rev Respir Med"},{"issue":"5","key":"10.1016\/j.chest.2024.10.050_bib10","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.mayocp.2020.08.033","article-title":"Excessive daytime sleepiness: a clinical review","volume":"96","author":"Gandhi","year":"2021","journal-title":"Mayo Clin Proc"},{"issue":"12","key":"10.1016\/j.chest.2024.10.050_bib11","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.5664\/jcsm.9610","article-title":"Indirect treatment comparison of solriamfetol, modafinil, and armodafinil for excessive daytime sleepiness in obstructive sleep apnea","volume":"17","author":"Ronnebaum","year":"2021","journal-title":"J\u00a0Clin Sleep Med"},{"key":"10.1016\/j.chest.2024.10.050_bib13","series-title":"Prmar-modafinil [product monograph]","year":"2017"},{"key":"10.1016\/j.chest.2024.10.050_bib15","series-title":"Nuvigil [package insert]","year":"2018"},{"key":"10.1016\/j.chest.2024.10.050_bib16","first-page":"221","article-title":"Armodafinil for sleep disorders","volume":"39","year":"2016","journal-title":"Aust Prescr"},{"key":"10.1016\/j.chest.2024.10.050_bib17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.smrv.2015.10.005","article-title":"Pharmacotherapy for residual excessive sleepiness and cognition in CPAP-treated patients with obstructive sleep apnea syndrome: a systematic review and meta-analysis","volume":"30","author":"Avellar","year":"2016","journal-title":"Sleep Med Rev"},{"issue":"4","key":"10.1016\/j.chest.2024.10.050_bib18","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.clinthera.2016.02.004","article-title":"Effects of modafinil and armodafinil in patients with obstructive sleep apnea: a meta-analysis of randomized controlled trials","volume":"38","author":"Kuan","year":"2016","journal-title":"Clin Ther"},{"key":"10.1016\/j.chest.2024.10.050_bib19","series-title":"Prescribing Information","year":"2022"},{"key":"10.1016\/j.chest.2024.10.050_bib20","series-title":"Sunosi [product monograph including patient medical information]","year":"2022"},{"key":"10.1016\/j.chest.2024.10.050_bib21","series-title":"Summary of Product Characteristics","year":"2023"},{"issue":"2","key":"10.1016\/j.chest.2024.10.050_bib22","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1124\/jpet.118.248120","article-title":"Characterization of the neurochemical and behavioral effects of solriamfetol (JZP-110), a selective dopamine and norepinephrine reuptake inhibitor","volume":"366","author":"Baladi","year":"2018","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"11","key":"10.1016\/j.chest.2024.10.050_bib23","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1164\/rccm.201806-1100OC","article-title":"Solriamfetol for excessive sleepiness in obstructive sleep apnea (TONES 3): a randomized controlled trial","volume":"199","author":"Schweitzer","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.chest.2024.10.050_bib24","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsz220","article-title":"Long-term study of the safety and maintenance of efficacy of solriamfetol (JZP-110) in the treatment of excessive sleepiness in participants with narcolepsy or obstructive sleep apnea","volume":"43","author":"Malhotra","year":"2020","journal-title":"Sleep"},{"issue":"8","key":"10.1016\/j.chest.2024.10.050_bib25","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1513\/AnnalsATS.202002-136OC","article-title":"Effects of solriamfetol on quality of life measures from a 12-week phase 3 randomized trial","volume":"17","author":"Weaver","year":"2020","journal-title":"Ann Am Thorac Soc"},{"issue":"10","key":"10.1016\/j.chest.2024.10.050_bib26","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.5664\/jcsm.9384","article-title":"Long-term effects of solriamfetol on quality of life and work productivity in participants with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea","volume":"17","author":"Weaver","year":"2021","journal-title":"J\u00a0Clin Sleep Med"},{"issue":"suppl 1","key":"10.1016\/j.chest.2024.10.050_bib27","doi-asserted-by":"crossref","first-page":"A329","DOI":"10.1093\/sleep\/zsac079.752","article-title":"Preclinical pharmacology of solriamfetol: potential mechanisms for wake promotion","volume":"45","author":"Gursahani","year":"2022","journal-title":"Sleep"},{"key":"10.1016\/j.chest.2024.10.050_bib28","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.neubiorev.2021.09.020","article-title":"Trace amine-associated receptor 1 (TAAR1): potential application in mood disorders: a systematic review","volume":"131","author":"Alnefeesi","year":"2021","journal-title":"Neurosci Biobehav Rev"},{"issue":"5","key":"10.1016\/j.chest.2024.10.050_bib30","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1378\/chest.14-0970","article-title":"International Classification of Sleep Disorders-Third Edition: highlights and modifications","volume":"146","author":"Sateia","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.chest.2024.10.050_bib31","series-title":"International Classification of Sleep Disorders","first-page":"53","article-title":"Obstructive sleep apnea, adult","year":"2014"},{"issue":"6","key":"10.1016\/j.chest.2024.10.050_bib32","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A\u00a0new method for measuring daytime sleepiness: the Epworth Sleepiness Scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"issue":"5","key":"10.1016\/j.chest.2024.10.050_bib33","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/JCP.0000000000000941","article-title":"Digit Symbol Substitution Test: the case for sensitivity over specificity in neuropsychological testing","volume":"38","author":"Jaeger","year":"2018","journal-title":"J\u00a0Clin Psychopharmacol"},{"issue":"2","key":"10.1016\/j.chest.2024.10.050_bib34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/104012371302500208","article-title":"Rapid screening for perceived cognitive impairment in major depressive disorder","volume":"25","author":"Iverson","year":"2013","journal-title":"Ann Clin Psychiatry"},{"issue":"12","key":"10.1016\/j.chest.2024.10.050_bib35","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","article-title":"The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults","volume":"168","author":"Posner","year":"2011","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.chest.2024.10.050_bib36","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1076\/jcen.26.1.43.23929","article-title":"Neurobehavioral functioning in obstructive sleep apnea: differential effects of sleep quality, hypoxemia and subjective sleepiness","volume":"26","author":"Naismith","year":"2004","journal-title":"J\u00a0Clin Exp Neuropsychol"},{"issue":"1","key":"10.1016\/j.chest.2024.10.050_bib37","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/sleep\/34.1.111","article-title":"The effect of CPAP in normalizing daytime sleepiness, quality of life, and neurocognitive function in patients with moderate to severe OSA","volume":"34","author":"Antic","year":"2011","journal-title":"Sleep"},{"issue":"2","key":"10.1016\/j.chest.2024.10.050_bib38","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsx199","article-title":"Determinants of sleepiness in obstructive sleep apnea","volume":"41","author":"Prasad","year":"2018","journal-title":"Sleep"},{"key":"10.1016\/j.chest.2024.10.050_bib39","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.sleep.2023.04.007","article-title":"Solriamfetol enhances wakefulness and improves cognition and anxiety in a murine model of OSA","volume":"107","author":"Badran","year":"2023","journal-title":"Sleep Med"},{"issue":"5","key":"10.1016\/j.chest.2024.10.050_bib40","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsad057","article-title":"Solriamfetol improves chronic sleep fragmentation-induced increases in sleep propensity and ameliorates explicit memory in male mice","volume":"46","author":"Puech","year":"2023","journal-title":"Sleep"},{"issue":"3","key":"10.1016\/j.chest.2024.10.050_bib41","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.rmed.2006.06.007","article-title":"Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea\/hypopnea syndrome","volume":"101","author":"Hirshkowitz","year":"2007","journal-title":"Respir Med"},{"issue":"2","key":"10.1016\/j.chest.2024.10.050_bib42","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.pnpbp.2007.10.016","article-title":"Placebo and modafinil\u00a0effect on sleepiness in obstructive sleep apnea","volume":"32","author":"Bittencourt","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"5","key":"10.1016\/j.chest.2024.10.050_bib43","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.clinthera.2006.05.013","article-title":"Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea\/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults","volume":"28","author":"Roth","year":"2006","journal-title":"Clin Ther"},{"issue":"1","key":"10.1016\/j.chest.2024.10.050_bib44","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11325-007-0137-7","article-title":"Armodafinil improves wakefulness and long-term episodic memory in nCPAP-adherent patients with excessive sleepiness associated with obstructive sleep apnea","volume":"12","author":"Roth","year":"2008","journal-title":"Sleep Breath"},{"issue":"2","key":"10.1016\/j.chest.2024.10.050_bib45","doi-asserted-by":"crossref","first-page":"143","DOI":"10.5664\/jcsm.3440","article-title":"Effect of armodafinil on cortical activity and working memory in patients with residual excessive sleepiness associated with CPAP-Treated OSA: a multicenter fMRI study","volume":"10","author":"Greve","year":"2014","journal-title":"J\u00a0Clin Sleep Med"},{"issue":"10","key":"10.1016\/j.chest.2024.10.050_bib46","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.sleep.2013.04.010","article-title":"Alertness and psychomotor performance effects of the histamine-3 inverse agonist MK-0249 in obstructive sleep apnea patients on continuous positive airway pressure therapy with excessive daytime sleepiness: a randomized adaptive crossover study","volume":"14","author":"Herring","year":"2013","journal-title":"Sleep Med"},{"issue":"8","key":"10.1016\/j.chest.2024.10.050_bib47","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1038\/npp.2015.52","article-title":"A\u00a0randomized, placebo-controlled, active-reference, double-blind, flexible-dose study of the efficacy of vortioxetine on cognitive function in major depressive disorder","volume":"40","author":"Mahableshwarkar","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"15","key":"10.1016\/j.chest.2024.10.050_bib48","first-page":"276","article-title":"On the proper use of the crossover design in clinical trials: part 18 of a series on evaluation of scientific publications","volume":"109","author":"Wellek","year":"2012","journal-title":"Dtsch Arztebl Int"},{"issue":"4","key":"10.1016\/j.chest.2024.10.050_bib49","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4097\/kja.21165","article-title":"Considerations for crossover design in clinical study","volume":"74","author":"Lim","year":"2021","journal-title":"Korean J Anesthesiol"},{"issue":"10","key":"10.1016\/j.chest.2024.10.050_bib50","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1017\/S1461145714000546","article-title":"A\u00a0randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults","volume":"17","author":"McIntyre","year":"2014","journal-title":"Int J Neuropsychopharmacol"}],"container-title":["CHEST"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369224054709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369224054709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:33:35Z","timestamp":1777390415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369224054709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0012369224054709"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2024.10.050","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Results of the Solriamfetol's Effect on Cognitive Health in Apnea Participants During a Randomized Placebo-Controlled Study (SHARP)","name":"articletitle","label":"Article Title"},{"value":"CHEST","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2024.10.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc under license from the American College of Chest Physicians.","name":"copyright","label":"Copyright"}]}}